Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Crescent Biopharma, Inc. - Common Stock
(NQ:
CBIO
)
18.56
+1.57 (+9.24%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 26, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Crescent Biopharma, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
Crescent Biopharma Announces Grants of Inducement Awards
June 26, 2026
From
Crescent Biopharma, Inc.
Via
GlobeNewswire
Crescent Biopharma Announces Grants of Inducement Awards
June 11, 2026
From
Crescent Biopharma, Inc.
Via
GlobeNewswire
Crescent Biopharma to Present at June Investor Conferences
June 02, 2026
From
Crescent Biopharma, Inc.
Via
GlobeNewswire
Crescent Biopharma Announces Grants of Inducement Awards
May 29, 2026
From
Crescent Biopharma, Inc.
Via
GlobeNewswire
Crescent Biopharma Announces Trial in Progress Presentation for ASCEND Study of CR-001, a PD-1 x VEGF Bispecific Antibody, at Upcoming American Society of Clinical Oncology (ASCO) 2026 Annual Meeting
May 21, 2026
From
Crescent Biopharma, Inc.
Via
GlobeNewswire
Crescent Biopharma Announces Grants of Inducement Awards
May 12, 2026
From
Crescent Biopharma, Inc.
Via
GlobeNewswire
Crescent Biopharma to Present at May Investor Conferences
May 06, 2026
From
Crescent Biopharma, Inc.
Via
GlobeNewswire
Which stocks are moving on Friday?
↗
May 01, 2026
Via
Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session.
↗
May 01, 2026
Via
Chartmill
Crescent Biopharma Reports First Quarter 2026 Financial Results and Recent Business Highlights
April 29, 2026
From
Crescent Biopharma, Inc.
Via
GlobeNewswire
Crescent Biopharma Announces Grants of Inducement Awards
April 24, 2026
From
Crescent Biopharma, Inc.
Via
GlobeNewswire
Crescent Biopharma Announces Grants of Inducement Awards
March 27, 2026
From
Crescent Biopharma, Inc.
Via
GlobeNewswire
Crescent Biopharma Announces Grants of Inducement Awards
March 06, 2026
From
Crescent Biopharma, Inc.
Via
GlobeNewswire
Crescent Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
February 26, 2026
From
Crescent Biopharma, Inc.
Via
GlobeNewswire
Crescent Biopharma to Present at March Investor Conferences
February 23, 2026
From
Crescent Biopharma, Inc.
Via
GlobeNewswire
Crescent Biopharma Announces Grants of Inducement Awards
February 19, 2026
From
Crescent Biopharma, Inc.
Via
GlobeNewswire
Crescent Biopharma Announces First Patient Dosed in ASCEND Phase 1/2 Clinical Trial of CR-001 for the Treatment of Advanced Solid Tumors
February 18, 2026
From
Crescent Biopharma, Inc.
Via
GlobeNewswire
Crescent Biopharma to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026
February 05, 2026
From
Crescent Biopharma, Inc.
Via
GlobeNewswire
Crescent Biopharma Announces Grants of Inducement Awards
January 30, 2026
From
Crescent Biopharma, Inc.
Via
GlobeNewswire
Crescent Biopharma Announces Regulatory Clearances of IND Applications for CR-001, a PD-1 x VEGF Bispecific Antibody and CR-003, an ITGB6-targeted ADC, for the Treatment of Solid Tumors
January 05, 2026
From
Crescent Biopharma, Inc.
Via
GlobeNewswire
Crescent Biopharma Announces Grants of Inducement Awards
December 18, 2025
From
Crescent Biopharma, Inc.
Via
GlobeNewswire
The Deal That Sent Crescent Biopharma Shares Surging Over 40% Pre-Market Today
↗
December 04, 2025
Crescent Biopharma announced a strategic partnership with the Chinese firm Sichuan Kelun-Biotech Biopharmaceutical Co. to fast-track its global oncology pipeline.
Via
Stocktwits
Crescent Biopharma Announces Transformational Partnership with Kelun-Biotech and $185 Million Private Placement, Accelerating and Expanding Global Pipeline of Next Generation Therapeutics for Solid Tumors
December 04, 2025
From
Crescent Biopharma, Inc.
Via
GlobeNewswire
Kelun-Biotech and Crescent Biopharma Announce Strategic Partnership to Develop and Commercialize Novel Oncology Therapeutics
December 04, 2025
From
Crescent Biopharma, Inc.; Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Via
GlobeNewswire
Crescent Biopharma Announces Grants of Inducement Awards
November 17, 2025
From
Crescent Biopharma
Via
GlobeNewswire
Crescent Biopharma Reports Third Quarter 2025 Financial Results and Recent Business Highlights
November 06, 2025
From
Crescent Biopharma
Via
GlobeNewswire
Crescent Biopharma to Present at November Investor Conferences
November 05, 2025
From
Crescent Biopharma
Via
GlobeNewswire
Crescent Biopharma to Present Preclinical Data for CR-001, a PD-1 x VEGF Bispecific Antibody, at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
November 04, 2025
From
Crescent Biopharma
Via
GlobeNewswire
Crescent Biopharma to Present at September Investor Conferences
August 28, 2025
From
Crescent Biopharma
Via
GlobeNewswire
This Devon Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
↗
August 25, 2025
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
